Determining How to Regulate Encapsulated Placenta
Scholar argues that FDA should use a narrowly tailored framework to regulate encapsulated placenta pills.
Got Soy Beverage?
Plant-based milk producers may soon no longer be able to put “milk” on their labels.
Regulations Coming Soon for Lab-Grown Meat
FDA and USDA’s plan to jointly regulate lab-made meat raises new questions for the future of food regulation.
The Case for Eating Bugs
Scholar argues FDA should regulate insects as food to help address food insecurity.
Judge Suspends Rules Expanding Exemptions to the Contraceptive Mandate
National injunction stops corporations from claiming religious or moral exemptions to birth control coverage.
How FDA Drug Review Contributed to the Opioid Epidemic
Scholars argue that FDA should use larger health data sets in its approval process for high-risk drugs.
Reforming Regulation to Promote Medical Use of Psychedelic Drugs
Expert argues for altering regulations on psychedelic drugs to treat mental illness and addiction.
Once They Are Tested, Can Genes Stay Private?
Scholars argue that increased use of direct-to-consumer genetic testing creates hidden privacy risks.
Lessons from State Implementation of Marijuana Legalization
States should learn from each other to confront the challenges of regulating marijuana.
How Regulators Can Increase Price Competition in Health Care
Scholars urge regulators to help level the playing field in contracting between health plans and hospitals.
Increasing Vaccination Rates Without Eliminating Nonmedical Exemptions
States should shift incentives to reduce nonmedical exemptions while respecting the choice not to vaccinate.
New Approach to Affordable Care Act Waivers Causes Controversy
The Trump Administration encourages states to use “innovation waivers” to find new ways to lower costs.